-55.8%
FIG vs MRNA
+511.3%
-567.1%
-76.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.4% | -2.2% | -2.1% | -4.3% |
| 7D | -16.3% | +5.5% | -21.8% | -16.5% |
| 30D | -14.3% | +158.7% | -173.0% | -22.0% |
| 3M | +7.2% | +182.1% | -175.0% | -3.8% |
| 6M | -18.6% | +151.8% | -170.4% | -25.5% |
| YTD | -35.5% | +393.6% | -429.0% | -50.4% |
| 1Y | -55.8% | +499.5% | -555.3% | -68.8% |
| All | -55.8% | +511.3% | -567.1% | -68.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling